Related references
Note: Only part of the references are listed.Efficient generation of gene-modified human natural killer cells via alpharetroviral vectors
Julia D. Suerth et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2016)
Alpharetroviral self-inactivating vectors produced by a superinfection-resistant stable packaging cell line allow genetic modification of primary human T lymphocytes
Verena Labenski et al.
BIOMATERIALS (2016)
Gene Insertion Into Genomic Safe Harbors for Human Gene Therapy
Eirini P. Papapetrou et al.
MOLECULAR THERAPY (2016)
A minimal ubiquitous chromatin opening element (UCOE) effectively prevents silencing of juxtaposed heterologous promoters by epigenetic remodeling in multipotent and pluripotent stem cells
Uta Mueller-Kuller et al.
NUCLEIC ACIDS RESEARCH (2015)
Efficient Recombinase-Mediated Cassette Exchange in hPSCs to Study the Hepatocyte Lineage Reveals AAVS1 Locus-Mediated Transgene Inhibition
Laura Ordovas et al.
STEM CELL REPORTS (2015)
Functionality of Endothelial Cells and Pericytes From Human Pluripotent Stem Cells Demonstrated in Cultured Vascular Plexus and Zebrafish Xenografts
Valeria V. Orlova et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Promoter and lineage independent anti-silencing activity of the A2 ubiquitous chromatin opening element for optimized human pluripotent stem cell-based gene therapy
Mania Ackermann et al.
BIOMATERIALS (2014)
Mystery solved: VSV-G-LVs do not allow efficient gene transfer into unstimulated T cells, B cells, and HSCs because they lack the LDL receptor
Fouzia Amirache et al.
BLOOD (2014)
Improved retroviral episome transfer of transcription factors enables sustained cell fate modification
J. W. Schott et al.
GENE THERAPY (2014)
Genetic correction of HAX1 in induced pluripotent stem cells from a patient with severe congenital neutropenia improves defective granulopoiesis
Tatsuya Morishima et al.
HAEMATOLOGICA (2014)
Modified Lentiviral LTRs Allow Flp Recombinase-mediated Cassette Exchange and In Vivo Tracing of Factor-free Induced Pluripotent Stem Cells
Johannes Kuehle et al.
MOLECULAR THERAPY (2014)
A Modified γ-Retrovirus Vector for X-Linked Severe Combined Immunodeficiency
S. Hacein-Bey-Abina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Reprogrammed Cells for Disease Modeling and Regenerative Medicine
Anne B. C. Cherry et al.
ANNUAL REVIEW OF MEDICINE, VOL 64 (2013)
Optimizing Retroviral Gene Expression for Effective Therapies
Michael N. Antoniou et al.
HUMAN GENE THERAPY (2013)
Alpharetroviral Vector-mediated Gene Therapy for X-CGD: Functional Correction and Lack of Aberrant Splicing
Kerstin B. Kaufmann et al.
MOLECULAR THERAPY (2013)
Kinetics and Epigenetics of Retroviral Silencing in Mouse Embryonic Stem Cells Defined by Deletion of the D4Z4 Element
Sylvie Rival-Gervier et al.
MOLECULAR THERAPY (2013)
LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus
Danit Finkelshtein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome
Alessandro Aiuti et al.
SCIENCE (2013)
A Ubiquitous Chromatin Opening Element Prevents Transgene Silencing in Pluripotent Stem Cells and Their Differentiated Progeny
Nils Pfaff et al.
STEM CELLS (2013)
Proviral Silencing in Embryonic Cells Is Regulated by Yin Yang 1
Sharon Schlesinger et al.
CELL REPORTS (2013)
Extensive Methylation of Promoter Sequences Silences Lentiviral Transgene Expression During Stem Cell Differentiation In Vivo
Friederike Herbst et al.
MOLECULAR THERAPY (2012)
Alpharetroviral Self-inactivating Vectors: Long-term Transgene Expression in Murine Hematopoietic Cells and Low Genotoxicity
Julia D. Suerth et al.
MOLECULAR THERAPY (2012)
The Impact of cHS4 Insulators on DNA Transposon Vector Mobilization and Silencing in Retinal Pigment Epithelium Cells
Nynne Sharma et al.
PLOS ONE (2012)
The Use of Chromatin Insulators to Improve the Expression and Safety of Integrating Gene Transfer Vectors
David W. Emery
HUMAN GENE THERAPY (2011)
Lentiviral Vector Design and Imaging Approaches to Visualize the Early Stages of Cellular Reprogramming
Eva Warlich et al.
MOLECULAR THERAPY (2011)
Genomic safe harbors permit high beta-globin transgene expression in thalassemia induced pluripotent stem cells
Eirini P. Papapetrou et al.
NATURE BIOTECHNOLOGY (2011)
Generation and genetic modification of induced pluripotent stem cells
Axel Schambach et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2010)
Self-Inactivating Alpharetroviral Vectors with a Split-Packaging Design
Julia D. Suerth et al.
JOURNAL OF VIROLOGY (2010)
A Ubiquitous Chromatin Opening Element (UCOE) Confers Resistance to DNA Methylation-mediated Silencing of Lentiviral Vectors
Fang Zhang et al.
MOLECULAR THERAPY (2010)
Quantitative Comparison of Constitutive Promoters in Human ES cells
Karin Norrman et al.
PLOS ONE (2010)
Protein transduction from retroviral Gag precursors
Christine Voelkel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Mechanism of Reduction in Titers From Lentivirus Vectors Carrying Large Inserts in the 3 ' LTR
Fabrizia Urbinati et al.
MOLECULAR THERAPY (2009)
Embryonic stem cells use ZFP809 to silence retroviral DNAs
Daniel Wolf et al.
NATURE (2009)
Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells
Angel Raya et al.
NATURE (2009)
Instability of retroviral DNA methylation in embryonic stem cells
Shigeru Minoguchi et al.
STEM CELLS (2008)
TRIM28 mediates primer binding site-targeted silencing of murine leukemia virus in embryonic cells
Daniel Wolf et al.
CELL (2007)
Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cells
Fang Zhang et al.
BLOOD (2007)
Stable gene expression occurs from a minority of integrated HIV-1-based vectors: transcriptional silencing is present in the majority
H. P. Mok et al.
GENE THERAPY (2007)
Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors
A. Schambach et al.
GENE THERAPY (2006)
Stable gammaretroviral vector expression during embryonic stem cell-derived in vitro hematopoietic development
Ali Ramezani et al.
MOLECULAR THERAPY (2006)
Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells
A Schambach et al.
MOLECULAR THERAPY (2006)
Silencing and variegation of gammaretrovirus and lentivirus vectors
J Ellis
HUMAN GENE THERAPY (2005)
Successful correction of the human β-thalassemia major phenotype using a lentiviral vector
G Puthenveetil et al.
BLOOD (2004)
Transgenes encompassing dual-promoter CpG islands from the human TBP and HNRPA2B1 loci are resistant to heterochromatin-mediated silencing
M Antoniou et al.
GENOMICS (2003)
Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates
V Sandrin et al.
BLOOD (2002)
Lentiviral vectors for enhanced gene expression in human hematopoietic cells
A Ramezani et al.
MOLECULAR THERAPY (2000)
Share Paper
